prikaz prve stranice dokumenta Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
  Preuzmi
PDF 611.15 KB
Znanstveni rad - Izvorni znanstveni rad
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
Blood Cancer Journal, 11 (2021), 11; 189. https://doi.org/10.1038/s41408-021-00585-2
Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sedinić, Martina; Sabljić, Anica; Derek, Lovorka; Jakšić, Ozren; Kušec, Rajko

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Lucijanić, M., Krečak, I., Sorić, E., Sedinić, M., Sabljić, A., Derek, L. ... Kušec, R. (2021). Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer Journal, 11. (11). doi: 10.1038/s41408-021-00585-2

Lucijanić, Marko, et al. "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism." Blood Cancer Journal, vol. 11, br. 11, 2021. https://doi.org/10.1038/s41408-021-00585-2

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Martina Sedinić, Anica Sabljić, Lovorka Derek, Ozren Jakšić i Rajko Kušec. "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism." Blood Cancer Journal 11, br. 11 (2021). https://doi.org/10.1038/s41408-021-00585-2

Lucijanić, M., et al. (2021) 'Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism', Blood Cancer Journal, 11(11). doi: 10.1038/s41408-021-00585-2

Lucijanić M, Krečak I, Sorić E, Sedinić M, Sabljić A, Derek L, i sur.. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer Journal [Internet]. 29.11.2021. [pristupljeno 17.01.2025.];11(11). doi: 10.1038/s41408-021-00585-2

M. Lucijanić, et al., "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism", Blood Cancer Journal, vol. 11, br. 11, Studeni 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:424560. [Citirano: 17.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:424560
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
AutorMarko Lucijanić
AutorIvan Krečak
AutorEna Sorić
AutorMartina Sedinić
AutorAnica Sabljić
AutorLovorka Derek
AutorOzren Jakšić
AutorRajko Kušec
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBlood Cancer Journal
Brojčani podacivol. 11, br. 11, 189
e-ISSN2044-5385
DOIhttps://doi.org/10.1038/s41408-021-00585-2
URN:NBNurn:nbn:hr:105:424560
Datum objave publikacije2021-11-29
URL dokumentahttps://www.nature.com/articles/s41408-021-00585-2
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2022-03-01 08:32:57